A patient presents on the same evening following thyroidectomy with a swelling in the neck and difficult breathing. What would be the immediate next management step?
The surgeon should be particularly concerned about which coagulation function in patients receiving anti-inflammatory or analgesic medications?
In cholecystectomy, when should fresh plasma be administered?
What is the preferred route for administering total parenteral nutrition (TPN) for a patient requiring it for less than 14 days?
A patient undergoes surgery in the pelvic region. Which vein is most likely to result in thrombosis?
A patient with Crohn's disease underwent resection anastomosis. On the 7th postoperative day, the patient presents with an anastomotic site leak forming a fistula, with a daily leakage volume of 150-200 ml. There is no intra-abdominal collection, and the patient is hemodynamically stable without any other complaints. What is the next line of management?
A 62-year-old woman undergoes a pancreaticoduodenectomy for a pancreatic head cancer. A jejunostomy is placed to facilitate nutritional repletion as she is expected to have a prolonged recovery. What is the best method for delivering postoperative nutrition?
A 52-year-old man with gastric outlet obstruction secondary to a duodenal ulcer presents with hypochloremic, hypokalemic metabolic alkalosis. Which of the following is the most appropriate therapy for this patient?
Which of the following is not usually a post-operative complication?
What is the most common postoperative complication in polycythemia vera?
Explanation: **Explanation:** The clinical presentation of neck swelling and respiratory distress immediately following a thyroidectomy is a surgical emergency, most commonly caused by a **tension hematoma**. This occurs due to arterial bleeding (often from the superior thyroid artery) under the deep cervical fascia, which compresses the trachea and causes laryngeal edema. **1. Why Option A is Correct:** In the context of post-thyroidectomy respiratory distress, the immediate priority is to **relieve the pressure**. While the definitive first step at the bedside is often "opening the wound/removing sutures" to evacuate the clot, in the context of these specific options, **Emergency Tracheostomy** (or securing the airway surgically) is the prioritized management to bypass the upper airway obstruction caused by laryngeal edema and tracheal compression. **2. Why the other options are incorrect:** * **B. Intubate oro-tracheally:** This is often technically impossible due to the external compression of the trachea and significant laryngeal edema. Attempting intubation may waste critical time. * **C & D. Observe/Administer Oxygen:** These are passive measures. A tension hematoma is a mechanical obstruction; oxygen cannot bypass the compression, and observation will lead to cardiac arrest. **Clinical Pearls for NEET-PG:** * **Most common cause of post-op respiratory distress (0-24 hours):** Tension Hematoma. * **Management Sequence:** 1. Immediate bedside removal of skin sutures and evacuation of the clot. 2. Secure airway (Intubation/Tracheostomy). 3. Return to OR for formal hemostasis. * **Other causes of post-thyroidectomy distress:** Bilateral Recurrent Laryngeal Nerve (RLN) injury (presents immediately after extubation) and Hypocalcemic tetany/laryngospasm (usually 24-72 hours post-op).
Explanation: **Explanation:** The correct answer is **Bleeding Time (D)**. **Why it is correct:** Anti-inflammatory and analgesic medications, specifically **Non-Steroidal Anti-inflammatory Drugs (NSAIDs)** like Aspirin, Ibuprofen, and Ketorolac, primarily affect **platelet function**. Aspirin irreversibly inhibits the enzyme cyclooxygenase-1 (COX-1), preventing the synthesis of Thromboxane A2, which is essential for platelet aggregation. Other NSAIDs cause reversible inhibition. Since the **Bleeding Time (BT)** is the primary clinical test used to assess the vascular phase and platelet plug formation (primary hemostasis), it is the parameter most affected by these drugs. **Why the other options are incorrect:** * **APTT (Activated Partial Thromboplastin Time):** This measures the integrity of the **intrinsic** and common coagulation pathways. It is used to monitor Heparin therapy, not NSAID use. * **PT (Prothrombin Time):** This measures the **extrinsic** and common pathways. It is used to monitor Warfarin therapy and liver synthetic function. * **Reptilase Time:** This measures the conversion of fibrinogen to fibrin. It is unaffected by heparin and is used to detect dysfibrinogenemia or contamination. **Clinical Pearls for NEET-PG:** * **Aspirin:** Should ideally be stopped **7–10 days** before major surgery (the lifespan of a platelet). * **NSAIDs (Non-selective):** Should typically be stopped **2–3 days** (approx. 5 half-lives) before surgery. * **Selective COX-2 Inhibitors (e.g., Celecoxib):** These do **not** affect platelet aggregation or bleeding time and can often be continued perioperatively. * **Normal Bleeding Time (Ivy’s Method):** 2–9 minutes.
Explanation: **Explanation:** In patients undergoing cholecystectomy who have underlying liver dysfunction or obstructive jaundice, the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X) is often impaired. **Fresh Frozen Plasma (FFP)** is administered to provide these essential clotting factors and prevent intraoperative hemorrhage. **Why "Just before operation" is correct:** The primary reason for this timing is the **short half-life of clotting factors**, particularly **Factor VII**, which has a half-life of only **4 to 6 hours**. If FFP is administered too early (e.g., 6 or 12 hours before), the concentration of these factors will drop below the therapeutic level by the time the surgeon makes the first incision. Administering it "on-call" to the operating theater ensures peak hemostatic efficacy during the most critical period of the surgery. **Analysis of Incorrect Options:** * **6 hours before operation:** By the time the surgery begins, the activity of Factor VII would have already diminished by half, increasing the risk of bleeding. * **12 hours after operation:** This is reactive rather than prophylactic. While it may help with post-operative oozing, it fails to prevent the primary risk of intraoperative hemorrhage. **Clinical Pearls for NEET-PG:** * **Vitamin K vs. FFP:** In elective cases with deranged PT/INR, Vitamin K is given parenterally for 3 days. If the surgery is **emergency** or the INR remains high despite Vitamin K, FFP is the treatment of choice. * **Dosage:** The standard dose of FFP is **10–15 mL/kg**. * **Indication:** FFP is generally indicated when the **Prothrombin Time (PT)** is >1.5 times the control or the **INR** is >1.5. * **Storage:** FFP is stored at **-18°C or colder** and must be used within 24 hours of thawing to maintain factor activity.
Explanation: ### Explanation The choice of access for Total Parenteral Nutrition (TPN) is primarily determined by the **duration of therapy** and the **osmolarity** of the solution. **1. Why Peripheral Vein is Correct:** For short-term nutritional support (typically **<14 days**), **Peripheral Parenteral Nutrition (PPN)** is preferred. It avoids the risks associated with central venous catheterization (e.g., pneumothorax, central line-associated bloodstream infections). However, to prevent thrombophlebitis, PPN solutions must have a lower osmolarity (usually **<800–900 mOsm/L**) and lower glucose concentration compared to central TPN. **2. Why Incorrect Options are Wrong:** * **Internal Jugular Vein (IJV):** This is a central venous access route. Central venous catheters (CVCs) or PICC lines are indicated for long-term TPN (**>14 days**) or when highly hypertonic solutions (>900 mOsm/L) are required to meet high caloric demands. Using the IJV for short-term needs unnecessarily increases the risk of major complications. * **External Jugular Vein (EJV):** While more superficial than the IJV, it is still considered a route for central access if the catheter tip reaches the superior vena cava. It is technically difficult to maintain for TPN and is not the standard "preferred" route for short-term peripheral administration. **3. High-Yield Clinical Pearls for NEET-PG:** * **Osmolarity Limit:** The maximum osmolarity tolerated by a peripheral vein is **900 mOsm/L**. Solutions exceeding this must be given via a central line to ensure rapid dilution in high-flow vessels. * **Most Common Complication of TPN:** Catheter-related sepsis (infection). * **Most Common Metabolic Complication:** Hyperglycemia. * **Refeeding Syndrome:** Characterized by **Hypophosphatemia** (most common), hypokalemia, and hypomagnesemia upon restarting nutrition in a starved patient. * **Duration Rule:** <2 weeks = Peripheral; >2 weeks = Central (CVC/PICC).
Explanation: **Explanation:** The correct answer is **Calf vein (Option C)**. Deep Vein Thrombosis (DVT) is a major postoperative complication, especially in pelvic and orthopedic surgeries. According to Virchow’s Triad (stasis, endothelial injury, and hypercoagulability), venous stasis is the primary driver during surgery due to immobilization and the effects of anesthesia. **Why Calf Veins?** Statistically, the **deep veins of the calf (soleal and gastrocnemius sinuses)** are the most common site for the initiation of thrombus formation. These veins are large, thin-walled, and lack valves, making them highly susceptible to blood pooling (stasis) when the calf muscle pump is inactive during surgery. While many calf thrombi are asymptomatic and resolve spontaneously, they serve as the precursor for proximal extension. **Analysis of Incorrect Options:** * **Iliac Vein (A) & Femoral Vein (B):** While these are "proximal" veins and carry a much higher risk of causing Pulmonary Embolism (PE) if they thrombose, they are **not** the most common initial site. Most iliofemoral thrombi actually originate in the calf and propagate upwards. * **Inferior Vena Cava (D):** Primary IVC thrombosis is rare and usually associated with congenital anomalies, tumors (like RCC), or long-term indwelling filters/catheters. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site for DVT initiation:** Calf veins (Soleal plexus). * **Most common source of clinically significant Pulmonary Embolism:** Iliofemoral veins (proximal DVT). * **Gold Standard Investigation for DVT:** Contrast Venography (rarely used now). * **Investigation of Choice (Initial):** Duplex Ultrasonography. * **Prophylaxis:** Early ambulation is the most effective physiological measure; LMWH is the pharmacological gold standard.
Explanation: ### Explanation **1. Why Option A is Correct:** The management of enterocutaneous fistulas (ECF) follows a structured approach, often summarized by the mnemonic **SNAP** (Sepsis control, Nutrition, Anatomy, Plan). In this scenario, the patient is **hemodynamically stable**, has **no intra-abdominal collection** (no sepsis), and the fistula is **low-output** (<200 ml/day). Statistically, 70-80% of enterocutaneous fistulas will close spontaneously with conservative management (bowel rest, TPN/enteral nutrition, and skin care) within 4-6 weeks, provided there are no "FRIEND" factors (defined below) preventing closure. Since the patient is stable and the leak is controlled, immediate re-operation is contraindicated as it is technically difficult due to dense adhesions and carries a high risk of creating further bowel injuries. **2. Why Other Options are Incorrect:** * **Options B, C, and D:** These involve immediate **Laparotomy**. Re-operating during the "obliterative peritonitis" phase (usually between day 7 and 6 weeks post-op) is hazardous. Surgery is only indicated in the acute phase if the patient has uncontrolled sepsis, generalized peritonitis, or a large undrained collection. Since this patient is stable, surgical intervention would be premature and likely lead to higher morbidity. **3. Clinical Pearls for NEET-PG:** * **Classification of ECF:** * Low output: <200 ml/day (Highest chance of spontaneous closure). * Moderate output: 200–500 ml/day. * High output: >500 ml/day. * **Factors preventing spontaneous closure (Mnemonic: FRIEND):** * **F**oreign body * **R**adiation * **I**nflammation/Infection (e.g., active Crohn’s) * **E**pithelialization of the tract * **N**eoplasm * **D**istal obstruction (The most common reason for failure of conservative Rx). * **Timing:** If a fistula doesn't close after **4–6 weeks** of optimal conservative therapy, surgical definitive repair is then planned.
Explanation: ### Explanation **Correct Answer: B. Institution of enteral feeding via the jejunostomy tube within 24 hours postoperatively.** #### Underlying Medical Concept The paradigm of postoperative care has shifted from "bowel rest" to **Early Enteral Nutrition (EEN)**. In major abdominal surgeries like pancreaticoduodenectomy (Whipple procedure), the small intestine retains its absorptive capacity and motility within 6–12 hours, even while the stomach (gastroparesis) and colon remain ileic. Starting enteral feeds via a jejunostomy within 24 hours maintains the gut mucosal barrier, reduces bacterial translocation, decreases the risk of infectious complications, and promotes faster wound healing compared to delayed feeding. #### Analysis of Incorrect Options * **Option A:** Waiting for the passage of flatus or bowel movements is an outdated practice. Small bowel function returns much earlier than colonic function; delaying nutrition until flatus occurs leads to a prolonged catabolic state. * **Option C:** This "wait and watch" approach is reactive rather than proactive. In high-risk surgeries like a Whipple, nutritional depletion occurs rapidly. Early initiation is preferred over supplemental use to prevent malnutrition. * **Option D:** While trophic feeds are beneficial, the routine use of Parenteral Nutrition (PN) is discouraged unless enteral feeding is contraindicated or fails to meet >60% of requirements after 7 days. PN is associated with higher costs and increased risks of line sepsis and metabolic derangements. #### NEET-PG High-Yield Pearls * **ERAS (Enhanced Recovery After Surgery) Protocols:** Emphasize early oral/enteral intake to reduce the "stress response" to surgery. * **Order of Return of Bowel Motility:** Small Intestine (6–12 hours) → Stomach (24–48 hours) → Colon (3–5 days). * **Preferred Route:** "If the gut works, use it." Enteral nutrition is always superior to parenteral nutrition due to its trophic effect on gut mucosa and lower infection rates. * **Jejunostomy Advantage:** It bypasses the stomach, which is frequently affected by delayed gastric emptying (DGE) post-pancreatic surgery.
Explanation: ### Explanation **1. Why Option A is Correct:** The patient presents with **Gastric Outlet Obstruction (GOO)**, leading to persistent vomiting of gastric juice (rich in H⁺, Cl⁻, and water). This results in **Hypochloremic Hypokalemic Metabolic Alkalosis**. The pathophysiology involves two phases: * **Initial Phase:** Loss of HCl and NaCl leads to volume depletion. The kidney attempts to conserve Na⁺ by exchanging it for H⁺ (Paradoxical Aciduria). * **Maintenance Phase:** To preserve volume, the kidney reabsorbs Na⁺ along with HCO₃⁻ (since Cl⁻ is deficient), perpetuating the alkalosis. The definitive treatment is **Isotonic Saline (0.9% NaCl)**. It provides Cl⁻, allowing the kidney to excrete HCO₃⁻, and restores volume, which shuts down the renin-angiotensin-aldosterone system. **Potassium (KCl)** is essential because as alkalosis is corrected, K⁺ shifts intracellularly, and the kidney stops "saving" K⁺ in exchange for Na⁺. **2. Why Other Options are Incorrect:** * **Option B:** HCl infusion is a "last-resort" therapy for life-threatening alkalosis (pH > 7.55) that is refractory to saline. It is not the initial treatment. * **Option C:** Clamping the NG tube is contraindicated. The stomach is already distended and obstructed; clamping increases the risk of aspiration and does not correct the existing electrolyte deficit. * **Option D:** Acetazolamide causes bicarbonate loss but worsens hypokalemia and volume depletion, which are the primary issues in GOO. **3. NEET-PG High-Yield Pearls:** * **Paradoxical Aciduria:** A hallmark of GOO where the urine is acidic despite systemic alkalosis (due to Na⁺/H⁺ exchange in the distal tubule to conserve volume). * **Fluid of Choice:** Normal Saline (0.9% NaCl). Avoid Ringer’s Lactate as the liver converts lactate to bicarbonate, worsening the alkalosis. * **Electrolyte Sequence:** Always correct volume and Cl⁻ first; K⁺ correction follows as the kidneys begin to function normally.
Explanation: The metabolic response to surgical stress is characterized by a neuroendocrine surge designed to maintain circulatory volume and mobilize energy. **Explanation of the Correct Answer:** **A. Hyponatremia:** This is **not** a typical physiological response to surgery. Following surgery, there is an increased secretion of **Aldosterone** (via the Renin-Angiotensin-Aldosterone System) and **ADH** (Vasopressin) due to stress and perceived volume loss. Aldosterone causes **sodium retention** and water reabsorption. While "dilutional hyponatremia" can occur if excessive hypotonic fluids are administered iatrogenically, the body’s primary physiological drive post-surgery is to conserve sodium. **Explanation of Incorrect Options:** * **B. Hypokalemia:** Aldosterone acts on the distal renal tubules to reabsorb sodium in exchange for **potassium excretion**. This leads to increased urinary potassium loss, making hypokalemia a common post-operative finding. * **C. Glucose Intolerance:** Surgical stress triggers the release of "counter-regulatory hormones" (Cortisol, Catecholamines, Glucagon, and Growth Hormone). these promote glycogenolysis and gluconeogenesis while inducing peripheral **insulin resistance**, leading to post-operative hyperglycemia. * **D. Negative N2 Balance:** Surgery induces a **catabolic state**. Skeletal muscle protein is broken down into amino acids to provide substrates for gluconeogenesis and acute-phase protein synthesis. This results in increased nitrogen excretion in urine, exceeding intake (Negative Nitrogen Balance). **NEET-PG High-Yield Pearls:** * **Phase of Injury:** The initial period after surgery is called the **"Ebb Phase"** (decreased BMR), followed by the **"Flow Phase"** (hypermetabolism). * **Most common electrolyte abnormality** post-operatively is often hypokalemia. * **ADH secretion** persists for 2–3 days post-op, making patients prone to fluid overload if not monitored.
Explanation: ### Explanation Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by an uncontrolled increase in red blood cell mass. This leads to **hyperviscosity** and an increased risk of both thrombosis and hemorrhage. **Why Cardiopulmonary Complications are Correct:** In the postoperative period, patients with PV are at a significantly high risk (up to 30%) of vascular complications. Hyperviscosity leads to sluggish blood flow, which, combined with the prothrombotic state of surgery, results in **thromboembolic events**. The most common and serious manifestations are **congestive heart failure (CHF)**, **myocardial infarction (MI)**, and **pulmonary embolism (PE)**. These are collectively categorized as cardiopulmonary complications. **Analysis of Incorrect Options:** * **A. Infection:** While any surgical patient is at risk for infection, it is not specifically increased by the pathophysiology of PV compared to the general population. * **C. Hemolysis:** PV involves the overproduction of cells, not their premature destruction. Hemolysis is more characteristic of conditions like G6PD deficiency or autoimmune hemolytic anemia. * **D. Uremia:** While hyperuricemia is common in PV (due to high cell turnover), frank uremia (renal failure) is not a primary or most common postoperative complication. **High-Yield Clinical Pearls for NEET-PG:** * **Preoperative Goal:** The most important step to reduce surgical morbidity in PV is to bring the **Hematocrit (Hct) below 45%** (ideally <42%) for at least 3–4 months prior to elective surgery. * **Management:** This is achieved through repeated **phlebotomy** and sometimes myelosuppressive agents (e.g., Hydroxyurea). * **Paradox:** Patients with PV are also at risk for **postoperative hemorrhage** due to qualitative platelet dysfunction, despite having high platelet counts.
Preoperative Risk Assessment
Practice Questions
Perioperative Management of Comorbidities
Practice Questions
Preparation of Patient for Surgery
Practice Questions
Informed Consent Process
Practice Questions
Post-Anesthesia Care
Practice Questions
Pain Management
Practice Questions
Wound Care and Dressings
Practice Questions
Drain Management
Practice Questions
Postoperative Complications Detection
Practice Questions
Early Ambulation and Rehabilitation
Practice Questions
Enhanced Recovery After Surgery (ERAS) Protocols
Practice Questions
Discharge Planning and Follow-up
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free